Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.

Clinical genetics - 1 Apr 2008

Evans D G R, Young K, Bulman M, Shenton A, Wallace A, Lalloo F

Abstract excerpt

While there are many reports in the literature of mutation testing of BRCA1 and BRCA2 in breast/ovarian cancer families, the question of which type of ovarian cancers are relevant still pertains. We have undertaken whole gene screening including multiple ligation-dependent probe amplification in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Ovarian Neoplasms

Share to Probability

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 18312450
DOI: 10.1111/j.1399-0004.2008.00974.x

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18312450-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.PMID 18312450Read ↗

Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.Semantic proximity Read ↗

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Cancer incidence in a population of Jewish women at risk of ovarian cancer.Semantic proximity Read ↗

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.Semantic proximity Read ↗

BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.Semantic proximity Read ↗

Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.Semantic proximity Read ↗

High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinomaSemantic proximity Read ↗

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.Semantic proximity Read ↗

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

The contribution of BRCA1 and BRCA2 to ovarian cancer.Semantic proximity Read ↗

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.